About us
Expertise
International
People
Careers
News & publications
Contact us
Home
»
News & publications
»
Latest news
News & publications
Related news & insights - Will Axtell
Penningtons Manches Cooper advises the shareholders of OXLiD on its acquisition by Gelion
Posted: 30/11/2023
The corporate team at Penningtons Manches Cooper has advised the shareholders of UK-based OXLiD on its acquisition by AIM listed Anglo-Australian battery innovator, Gelion. OXLiD is an Oxford based lithium-sulfur (Li-S) battery technology developer. Its work concerns the development and commercialisation of Li-S batteries......>>
Penningtons Manches Cooper advises the shareholders of machine vision technology specialists Industrial Vision Systems on its acquisition by Oxford Metrics
Posted: 03/11/2023
The corporate team at Penningtons Manches Cooper has advised the shareholders of machine vision technology specialists Industrial Vision Systems on its acquisition by Oxford Metrics PLC (LSE: OMG). Based in Oxfordshire, Industrial Vision Systems’ innovative machine vision systems are used globally in automated production processes......>>
Penningtons Manches Cooper advises Hutano Diagnostics Limited on its sale to EDX Medical Group PLC
Posted: 23/10/2023
The corporate team at Penningtons Manches Cooper has advised Oxford-based Hutano Diagnostics Limited, an innovative, quantitative, multiplex point of care testing platform, on its sale to EDX Medical Group PLC. Founded in 2018, Hutano Diagnostics’ mission is to enable accurate and timely disease prognosis, diagnosis......>>
Penningtons Manches Cooper advises Cibus Fund II on its acquisition of leading UK cell-grown tree producer Alba Trees
Posted: 27/02/2023
The corporate team at Penningtons Manches Cooper has advised Cibus Fund II (Cibus), the specialist sustainable food and agriculture fund, on the successful acquisition of Alba Trees Limited. Cibus is a sustainable food and agriculture firm based in London. Founded in 2016, it advises on investments by the Cibus funds into new and innovative......>>
Penningtons Manches Cooper advises Source Health Economics on its sale to Waterland-backed SCIRIS
Posted: 19/01/2023
The corporate team at Penningtons Manches Cooper has advised Source Health Economics, an agency specialising in health economics and outcomes research, on its sale to SCIRIS. Founded in 2016, Source Health Economics comprises a team of specialists in health economics, statistics, medical writing, systematic review, meta-analysis......>>
Penningtons Manches Cooper advises leading provider of testing, consulting, information, and compliance services, Smithers, on its acquisition of ResChem Analytical Limited
Posted: 19/01/2023
The corporate team at Penningtons Manches Cooper has advised Smithers, a leading provider of testing, consulting, information, and compliance services, on its acquisition of ResChem Analytical Limited. Founded in 1925 and headquartered in Akron, Ohio, Smithers is a multinational provider of testing, consulting, information, and compliance services......>>
Penningtons Manches Cooper advises Simply Sustainable on its majority investment from Agathos Management LLP
Posted: 04/01/2023
The corporate team at Penningtons Manches Cooper has advised the shareholders of Simply Sustainable, a London-headquartered ESG and sustainability consultancy known for its deep sustainability expertise, on the majority investment from Agathos Management LLP, a lower mid-market private equity firm......>>
Penningtons Manches Cooper advises SiXworks on their investment from Chiltern Capital
Posted: 04/11/2022
The corporate team at Penningtons Manches Cooper has advised SixWorks, a rapidly growing designer and implementer of specialist and complex IT solutions for highly secure critical risk environments within the public sector, on their investment from Chiltern Capital......>>
Penningtons Manches Cooper advises Titian Software on majority investment from Battery Ventures
Posted: 12/07/2022
The corporate team at Penningtons Manches Cooper has advised shareholders of Titian Software, a leading sample management software solution provider to the life sciences sector, on the significant, majority investment from Battery Ventures, a US technology-focused investment firm. Titian will use the new funds to support organic growth as well as potential future acquisitions......>>
Penningtons Manches Cooper advises US company Echo Healthcare on its cross-border acquisition of Immersive Interactive
Posted: 17/06/2022
The corporate team at Penningtons Manches Cooper has advised Echo Healthcare Inc, a US medtech company, on its strategic cross-border acquisition of Immersive Interactive......>>
1
2
3
4
Filter news & insights
Filter by keyword:
Filter by expertise:
Select an area of expertise
Banking and finance
Cauda Equina Syndrome claims
Charities
Clinical negligence
Commercial
Company secretarial services
Construction and infrastructure
Corporate
Corporate tax
Cosmetic surgery claims
Court of Protection and deputyships
Cyber security and cyber crime
Cycle and bike accident claims
Data protection and privacy
Digital business
Education
Elderly care claims
Employee share schemes
Employment for Business
Employment for Individuals
Energy regulatory
Equity capital markets
Family law
Fashion and luxury brands
Financial services
Financial services regulation
Fintech
Funding a personal injury claim
Gender pay gap reporting
Holiday accident claims
Hospital fall claims
Housing
Housing governance
Immigration for Business
Inquest representation
Inquest representation
Intellectual property
International trade
IT and telecommunications
Life sciences
Marine, trade and energy
Ophthalmology claims
Pensions
Personal injury
Planning
Private client and tax
Product liability claims
Product liability claims
Real estate
Real estate investors
Real estate litigation
Regulatory compliance
Renewable energy and cleantech
Residential property and conveyancing
Retail
Shipping
Social housing management
Sports
Stillbirth and neonatal death claims
Surgical error claims
Technology
Technology transfer and spin-outs
Vaginal mesh claims
In this section
Latest news
Archive news
Publications
Media enquiries
Contact our press team on:
+44 (0)20 7457 3258
+44 (0)7887 888105 (out of hours)